PD04: The Lymphedema Treatment Act in Action: What’s Changed, What’s Next
Since its implementation in 2024, the Lymphedema Treatment Act (LTA) has significantly reshaped coverage and access to compression therapy across the U.S. This session will explore the real-world effects of the LTA across Medicare, Medicaid, Managed Care, and private insurance. We’ll examine how various stakeholders—including clinicians, DME suppliers, and patients—have been impacted, and what challenges and opportunities remain. Attendees will gain insight into policy trends, billing practices, and advocacy strategies shaping the future of lymphedema care.
Speakers
Carmen AndersonConsultant, US Medical Compression Alliance
Noel NeilChief Compliance Officer, ACU-Serve LLC
More Information
Allow Registration:No
Capacity Unlimited:Yes
Do you feel as though there is a topic missing?:No
If yes, who would you recommend as your fellow panelist?:Noel Neil
Please include five learning objectives::1. Identify key provisions of LTA 2. Analyze impact on patient access, coverage policies, and reimbursement 3. Examine operational and clinical implications for stakeholders 4. Compare implementation differences across payers 5. Develop strategies for fut
